Literature DB >> 28644246

Effects of Exercise on the Immune Function of Pediatric Patients With Solid Tumors: Insights From the PAPEC Randomized Trial.

Carmen Fiuza-Luces1, Julio R Padilla, Jaime Valentín, Elena Santana-Sosa, Alejandro Santos-Lozano, Fabián Sanchis-Gomar, Helios Pareja-Galeano, Javier S Morales, Steven J Fleck, Margarita Pérez, Alvaro Lassaletta, Luisa Soares-Miranda, Antonio Pérez-Martínez, Alejandro Lucia.   

Abstract

The purpose of this study was to assess the effects of an in-hospital exercise intervention during neoadjuvant chemotherapy on the inflammatory profile and immune cell subpopulation in 20 children with solid tumors (control [n = 11] and exercise group [n = 9]). Although no significant interaction (group × time) effect was found with an analysis of variance test, we found a trend toward an interaction effect for natural killer cells expressing the immunoglobulin-like receptor KIR2DS4, with their numbers remaining stable in the exercise group but increasing in controls. Our data support that exercise interventions are safe in pediatric cancer patients with solid tumors during chemotherapy treatment despite its aggressive, immunosuppressive nature.

Entities:  

Mesh:

Year:  2017        PMID: 28644246     DOI: 10.1097/PHM.0000000000000757

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  10 in total

Review 1.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 2.  Supervised Exercise Interventions in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Qing Shi; Junyi Zheng; Ke Liu
Journal:  Children (Basel)       Date:  2022-06-02

Review 3.  Recommendations for Resuming PA after Prolonged Rest in Children and Adolescents: A Systematic Integrative Review of Relevance for Immunity.

Authors:  Antonio Cicchella
Journal:  J Funct Morphol Kinesiol       Date:  2022-06-02

Review 4.  Exercise and Childhood Cancer-A Historical Review.

Authors:  Javier S Morales; Pedro L Valenzuela; Daniel Velázquez-Díaz; Adrián Castillo-García; David Jiménez-Pavón; Alejandro Lucia; Carmen Fiuza-Luces
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

5.  Exercise Training and Natural Killer Cells in Cancer Survivors: Current Evidence and Research Gaps Based on a Systematic Review and Meta-analysis.

Authors:  Pedro L Valenzuela; Gonzalo Saco-Ledo; Alejandro Lucia; Carmen Fiuza-Luces; Alejandro Santos-Lozano; Javier S Morales; Adrián Castillo-García; Richard J Simpson
Journal:  Sports Med Open       Date:  2022-03-04

6.  Effects of Exercise Interventions on Immune Function in Children and Adolescents With Cancer and HSCT Recipients - A Systematic Review.

Authors:  Ronja Beller; Sabrina Bianca Bennstein; Miriam Götte
Journal:  Front Immunol       Date:  2021-09-27       Impact factor: 7.561

Review 7.  Therapeutic exercise interventions in pediatric survivors of brain cancer and other solid tumors: A scoping review.

Authors:  Brooke E Kohler; Carolina X Sandler; Emmah Baque; Natalie K Bradford; Stewart G Trost
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

8.  Physiological and mental health changes in cancer patients during the COVID-19 state of emergency.

Authors:  Borja Gutiérrez-Santamaría; Arkaitz Castañeda-Babarro; Maria Soledad Arietaleanizbeaskoa; Nere Mendizabal-Gallastegui; Gonzalo Grandes; Aitor Coca
Journal:  Sport Sci Health       Date:  2022-10-01

9.  EFFECTS OF PHYSICAL EXERCISE DURING HOSPITALIZATION IN CHILDREN AND ADOLESCENTS WITH CANCER: A SYSTEMATIC REVIEW.

Authors:  Scárlat da Silva Santos; Luciane Dalcanale Moussalle; João Paulo Heinzmann-Filho
Journal:  Rev Paul Pediatr       Date:  2020-10-05

Review 10.  Impact of physical activity and energy restriction on immune regulation of cancer.

Authors:  Yitong Xu; Connie J Rogers
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.